Yes there’s only like 11 million shares to this company and maybe 8 million warrants at higher prices. They have 3 good pipeline s of new drugs. First one will shoot it to 30 once nda gets approval. This one should be 8$ already with the low float. It will be bought and taken out buy a big eye company and the ulcerative colitis will be bought or co sold with Merck or another big boy wait and see
PTN Palatin Technologies, Inc.
Stock Split History (link goes to Seeking Alpha)
Aug. 31, 2022 1:25
Sep. 27, 2010 1:10
Sep. 08, 1997 1:4
Jul. 22, 1996 1:10
Well at $8 I am ahead. $ 20 makes this a home run.
Company’s future and products. If they start selling sex drug Europe then profits going up. But there pipeline is in stage 2 and 3 drugs with eye drug will be a good deal with all the old people in the USA. Those drugs are expensive any eye drops. They will partner up with some big company for there sales force and probably get a payment up front and royalties then the Ibs drug comes out of the pipe game on. HW a research company has company valued at 75$ a share.
You have any idea why the stock has been strong the past two days. I saw nothing in the quarterly report that was dramatic but maybe I missed something.
Amen brother. :)
Article on bio pharm companies cheap and getting bought out for there pipelines. Matter of time. Promethius Ibs drug taken out for 200$a share. Hang on for the ride. Somebody hold this one down and buying up the shares. Company should sell everybody here happy with 50$ a share right.
Not going anywhere Zeus. I have this is in my ROTH and in it for the long haul. News on Vyleesi looks solid today also.
We should only be so fortunate.
At this point why would anyone pay $70/s when they can accumulate shares for $3/s?
First we need to get to $7 lol.
Another case of a whale screwing the retail investor. I hope they get caught in a short squeeze.
After the trashing this stock has taken that would be welcome.